Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells.
Curr Cancer Drug Targets. 2024 Jan 4. doi: 10.2174/0115680096260614231115192343. Online ahead of print.
Curr Cancer Drug Targets. 2024.
PMID: 38178674
Cite
Cite